Generate a tailored SOP for Dr. Renée Douville. Improve your application with a focused, well-structured draft.
Renée N. Douville is an associate professor in the Department of Pharmacology and Therapeutics at the University of Manitoba and principal investigator in the Division of Neurodegenerative Disorders at the St. Boniface Hospital Albrechtsen Research Centre. With expertise in human endogenous retroviruses and their potential roles in neurological disease, her research focuses on the activity of endogenous retrovirus-K (ERVK) in amyotrophic lateral sclerosis (ALS). Douville's lab is investigating new viral proteins such as conotoxin-like protein (CTXLP) and their therapeutic potential in targeting ERVK integrase as a strategy to treat motor neuron diseases. She has held previous positions as a full professor in the Department of Biology at the University of Winnipeg, where her work contributed to a deeper understanding of the molecular aspects of neurodegeneration. Douville’s mission is to develop antiviral drugs to tackle neurodegenerative diseases such as ALS and dementia, providing hope for effective treatments in these currently incurable conditions.
Streams include Education, Administration, or Clinical.